More than cell therapy manufacturing
No matter where you are in your cell therapy workflow, we offer scientific support that removes friction at every stage of the journey and evolves with the industry.
In cell therapy, progress carries real urgency. Advancing from early development toward clinical and commercial GMP manufacturing means navigating process variability, scale-up, and regulatory complexity.
To keep progress on track, we deliver solutions that support both today’s discovery and tomorrow’s demand—enabling reliable workflows and a clear path to scale.
No matter where you are in your cell therapy workflow, we offer scientific support that removes friction at every stage of the journey and evolves with the industry.
We were lucky to be part of the pioneering work that turned the earliest CAR T vision into a real-life treatment ― and we haven’t stopped innovating since.
Advanced tools and strategies we’re delivering to address current demands for scale, consistency, and affordability in cell therapy.
Emerging approaches our teams are developing to help redefine complex disease treatment and patient care.

Increase productivity through automated, small‑footprint workflows designed for parallel processing.
Thoughtfully designed to help you overcome the biggest hurdles in cell therapy manufacturing.
Scale from R&D to commercialization with modular workflows that adapt as demand grows and processes evolve.
Enable process standardization with digital workflows and batch records that support control, traceability, and regulatory readiness.
Improve process reliability and productivity while reducing the risk of contamination and batch failure.